Home » Stocks » SRTS

Sensus Healthcare, Inc. (SRTS)

Stock Price: $3.84 USD -0.07 (-1.79%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 63.37M
Revenue (ttm) 12.99M
Net Income (ttm) -6.81M
Shares Out 16.45M
EPS (ttm) -0.42
PE Ratio n/a
Forward PE 23.15
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $3.84
Previous Close $3.91
Change ($) -0.07
Change (%) -1.79%
Day's Open 3.90
Day's Range 3.82 - 3.94
Day's Volume 5,630
52-Week Range 1.83 - 4.71

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

BOCA RATON, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost...

Seeking Alpha - 2 months ago

Sensus Healthcare' (SRTS) CEO Joe Sardano on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today

GlobeNewsWire - 2 months ago

BOCA RATON, Fla, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-...

GlobeNewsWire - 2 months ago

BOCA RATON, Fla. , Oct. 29, 2020 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncolo...

Seeking Alpha - 5 months ago

Sensus Healthcare' (SRTS) CEO Joe Sardano on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today

GlobeNewsWire - 5 months ago

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems

GlobeNewsWire - 5 months ago

Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the state

GlobeNewsWire - 5 months ago

BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both onc...

GlobeNewsWire - 5 months ago

BOCA RATON, Fla. , July 28, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and c...

GlobeNewsWire - 6 months ago

BOCA RATON, Fla., July 13, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncolo...

GlobeNewsWire - 6 months ago

BOCA RATON, Fla. , June 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncol...

GlobeNewsWire - 6 months ago

BOCA RATON, Fla, June 24, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncologic...

GlobeNewsWire - 7 months ago

June 18 Event is the Third in a Series of Topical Discussions

Seeking Alpha - 8 months ago

Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT

Seeking Alpha - 11 months ago

Sensus Healthcare's (SRTS) CEO Joe Sardano on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 11 months ago

BOCA RATON, Fla, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cos...

GlobeNewsWire - 1 year ago

New corporate structure positions company for 2020 financial goals

GlobeNewsWire - 1 year ago

BOCA RATON, Fla., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and...

Seeking Alpha - 1 year ago

Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Sensus Healthcare's (SRTS) CEO Joe Sardano on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Sensus Healthcare's (SRTS) CEO Joe Sardano on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Today, we look at a small medical device maker based in South Florida.

About SRTS

Sensus Healthcare manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetr... [Read more...]

Industry
Medical Devices
IPO Date
Jun 3, 2016
CEO
Joseph Sardano
Employees
53
Stock Exchange
NASDAQ
Ticker Symbol
SRTS
Full Company Profile

Financial Performance

In 2019, SRTS's revenue was $27.26 million, an increase of 3.16% compared to the previous year's $26.43 million. Losses were -$1.70 million, -15.96% less than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is 4.43, which is an increase of 15.36% from the latest price.

Price Target
$4.43
(15.36% upside)
Analyst Consensus: Buy